David M. King

Also affiliated with Integrity Testing Laboratory (Canada), Technical Directions Incorporation (United States), Metro-Minnesota Community Oncology Research Consortium

MedicineEngineeringMaterials SciencePhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)”.

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

Journal of Clinical Oncology(2024)10.1200/jco.23.01100

N/A

0.648DataRank · unranked

21 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12004

N/A

0DataRank · unranked

7 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more